This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Feb. 8, 2012 /PRNewswire/ --
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release 2011 year-end financial results after the market closes on
Wednesday, February 29, 2012. A conference call and live Internet webcast will be held on
Wednesday, February 29, 2012, at
5:00 p.m. Eastern Time to discuss the results.
To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 50392851. The live webcast and rebroadcast can be accessed via
Cumberland's website at
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology.
Cumberland's marketed products include Acetadote
acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor® (
ibuprofen) Injection, the first injectable treatment for pain and fever approved in
the United States, and Kristalose® (
lactulose) for Oral Solution, a prescription laxative.
Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information on
Cumberland, please visit the Company's website at
SOURCE Cumberland Pharmaceuticals Inc.